Project Details
Personalized Foetal Organoids for Severity Prediction in Congenital Diaphragmatic Hernia
Applicant
Dr. Carolin Riemer
Subject Area
General and Visceral Surgery
Medical Physics, Biomedical Technology
Medical Physics, Biomedical Technology
Term
since 2025
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 575551032
Congenital Diaphragmatic Hernia (CDH) is a severe developmental anomaly with complex pathophysiology and a persistently imprecise outcome prediction. Building on recent breakthroughs in patient-derived organoid technology pioneered by Doctor Gerli and Professor De Coppi's laboratories at UCL, this project aims to significantly advance personalised prognostication and understanding of CDH. Leveraging a unique cohort of human amniotic fluid-derived lung organoids derived from CDH patients, paired with their corresponding comprehensive clinical data, the project will systematically investigate and characterise direct correlations between in vitro organoid characteristics and the diverse clinical outcomes suffered by the patients. This crucial correlative analysis, bridging cutting-edge organoid modelling with clinical reality, will define novel individualised biomarkers, enable more precise patient counselling and stratification, guiding personalised antenatal interventions (i.e., FETO), and ultimately lead to improved long-term outcomes for affected children.
DFG Programme
WBP Fellowship
International Connection
United Kingdom
